Cite
[Case Report of Long-Term Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Stage Ⅳ AdvancedBreast Cancer].
MLA
Sugimoto, Hitoshi, et al. “[Case Report of Long-Term Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Stage Ⅳ AdvancedBreast Cancer].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 46, no. 13, Dec. 2019, pp. 2246–48. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=32156893&authtype=sso&custid=ns315887.
APA
Sugimoto, H., Miura, T., Kawamura, Y., Aburatani, T., Hanaoka, M., Ogo, T., Hoshino, N., Nishioka, Y., & Kawano, T. (2019). [Case Report of Long-Term Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Stage Ⅳ AdvancedBreast Cancer]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 46(13), 2246–2248.
Chicago
Sugimoto, Hitoshi, Tomiyuki Miura, Yudai Kawamura, Tomoki Aburatani, Marie Hanaoka, Taichi Ogo, Naoaki Hoshino, Yoshinobu Nishioka, and Tatsuyuki Kawano. 2019. “[Case Report of Long-Term Clinical Efficacy of Paclitaxel plus Bevacizumab Combination Therapy for Stage Ⅳ AdvancedBreast Cancer].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 46 (13): 2246–48. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=32156893&authtype=sso&custid=ns315887.